Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment - Giuliano, Mario; Giordano, Antonio; Jackson, Summer; Hess, Kenneth R; De Giorgi, Ugo; Mego, Michal; Handy, Beverly C; Ueno, Naoto T; Alvarez, Ricardo H; De Laurentiis, Michelino; De Placido, Sabino; Valero, Vicente; et al. (Breast cancer research : BCR, 2011)
Keywords: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized - therapeutic use; Bevacizumab; Biomarkers, Tumor - blood; Biomedical and Life Sciences; Biomedicine; Breast cancer; Breast Neoplasms - drug therapy; Breast Neoplasms - pathology; Cancer Research; Care and treatment; Cell Line, Tumor; Cells, Cultured; Development and progression; Diagnosis; Disease Progression; Drug therapy, Combination; Female; Health aspects; Humans; Metastasis; Middle Aged; Neoplastic Cells, Circulating; Oncology; Physiological aspects; Predictive Value of Tests; Prognosis; Quinazolines - therapeutic use; Receptor, Epidermal Growth Factor - biosynthesis; Research Article; Surgical Oncology; Trastuzumab; United States; Italy; Lapatinib; Circulate Tumor Cell; Overall Survival; Trastuzumab; Bevacizumab